L
aser-induced fluorescence (LIF) spectroscopy has been used in vitro and in vivo to distinguish normal LIF Measurement System from malignant tissue in different organs, such as the The LIF system has been described previously. 6 Figure breast, lung, colon, and esophagus. [1] [2] [3] [4] [5] [6] These studies 1 shows a schematic diagram of the overall system. In sumclearly show the potential application of LIF spectroscopy as a noninvasive diagnostic technique. However, most of nosed by the clinician. In gastroenterology, the impor-990-HQ) controlled by an optical multichannel analyzer (OMA III; EG&G Princeton Applied Research). The diode array allowed simultaneous analysis of a wide range of wavelengths within seconds (1023 different wavelengths, corresponding to the number of active diodes). Synchronization of laser pulses and gating of the intensified diode array was achieved by programming a 1336-nanosecond delay between laser trigger and detector activation. The intensifier was gated for 100 nanoseconds, during which a 5-nanosecond laser pulse was delivered to the tissue. The diode array was spectrally calibrated using a mercury/argon spectral calibration lamp (model 6035; Oriel Corp., Stratford, CT).
A personal computer (model 486DX2, 50 MHz; Gateway 2000, North Sioux City, SD) was used to control the entire system. OMA-Vision-PDA spectroscopy software (EG&G Princeton Applied Research) was used to conduct the measure- ments. This software allowed automatic storage of spectra into the hard disk with a file name coded using a combination of numbers representing the current date and a three-digit file mary, a nitrogen-pumped dye-laser (model LC300C; Laser number. Each measurement was conducted and stored on the Photonics, Inc., Orlando, FL) was used to deliver 5-nanosecond hard disk by depressing a foot switch attached to the keyboard pulses of excitation light. The dye laser was tuned to generate to allow remote activation of the measurements by the endospulses of 410-nm light for excitation of tissue proven to be copist. Each measurement required 1-2 seconds for processing effective for detection of esophageal cancer.
6, 17 The rationale and storage. for this excitation wavelength has been discussed previously. 6 The software was operated in accumulate/subtract mode. In The pulse energy was highly stable with a typical energy of this mode, the following three operations form a measurement 20.0 { 0.3 mJ. This pulsed laser is suitable for such studies cycle: the optical multichannel analyzer system sends a trigger because it provides a sufficient amount of energy per pulse signal to the excitation laser; after a programmed delay of that can be coupled easily to a fiber or fiber bundle. The laser 1336 nanoseconds, the optical multichannel analyzer system was activated externally by an optical multichannel analyzer also sends a signal to the detector to be activated; and the to allow synchronization with a gated intensified diode array.
optical multichannel analyzer system performs background Such a system allows fluorescence measurements without conmeasurement, subtracts the background from the signal, and cern for background light interference.
stores/adds the result in memory. In this study, 10 emission The laser beam was coupled via a quartz lens to the excitascans from tissue were accumulated per measurement, and the tion fibers of a sheathed fluorescence probe (C Technologies, result was stored in the hard disk. Verona, NJ). The probe was constructed of seven 200-mm fibers for delivery of the excitation light and 12 200-mm fibers Overall System Response surrounding the excitation fibers for collection of tissue fluorescence emission. The distal end of the probe (the end that To assure optimum system performance, the fluoresis passed through the scope and comes in contact with the cence of a standard dye solution (kiton red) and the laser pulse tissue) was flat and was encased in a 4-mm-long hypodermic energy were measured among all patients. In this manner, any tube with an outside diameter of 1.7 mm. The output end of variation in fluorescence signal caused by laser energy, detector the collection fibers (the end that is attached to the spectrogain, or probe damage could be detected and corrected immegraph) was arranged in a linear array of 1 1 12 fibers to match diately. It should be emphasized that fluorescence line shape the entrance slit of the spectrograph. The length of this fiber is independent of fluorescence emission intensity. Therefore, assembly was 6 m. The overall outside diameter of the probe, laser pulse energy and standard dye fluorescence intensity were including the protective sheath, was 2.4 mm.
not needed for calculation of fluorescence line shape. The linear array of collection fibers formed the input to the entrance slit of a f/3.8, 0.28-m triple-grating spectrograph and touched it lightly to the tissue. Measurements were initiated by pressing the foot switch. The collected spectra were The spectrally dispersed emission spectrum was imaged on a gated intensified 1024-diode array detector (model 1456B-automatically saved in separate coded data files. 
Endoscopic Fluorescence Measurement

Dysplasia in Barrett's Mucosa
Four-quadrant pinch biopsy specimens were then obtained from where fluorescence measurements were taken. The majorThe fluorescence spectra from Barrett's mucosa were ity of the biopsies were performed using jumbo forceps. The analyzed using the DNF models to determine whether highpinch biopsy results were used for tabulation of the fluorescence grade dysplasia could be diagnosed in patients with Barrett's spectra.
esophagus. In this study, the DNF indices classified each spectrum as either premalignant or benign, noting that all spectra
Differential Normalized Fluorescence
were taken from Barrett's mucosa with and without dysplasia
Spectral Analysis
and without any cancer. Each spectrum was classified using two different DNF indices, DNF 480 and DNF 660 , where A mathematical model based on the differential nor-DNF 480 and DNF 660 were defined previously. malized fluorescence (DNF) index has been developed for the In summary, all collected fluorescence spectra were analyzed endoscopic LIF diagnosis of esophageal cancer. 17 A brief deas follows: each spectrum was first normalized, DNF 480 and scription of the development of the model is given here. DNF 660 indices were obtained for each normalized spectrum, The total integrated light (sum of all photons detected by the DNF 480 and DNF 660 indices classified each spectrum as the selected diodes within the array) from 430 nm to 716 nm either benign or premalignant based on the model described was determined for each measured fluorescence spectrum. All above, and the classifications results were then verified/comfluorescence spectra were normalized with respect to the total pared with histological results. integrated light. A set of normalized fluorescence spectra from 15 patients with normal esophagus (squamous epithelium)
Data Tabulation Methods
were collected and used to determine an average normalized fluorescence spectrum to be used as a baseline value. Although
Measurements from 36 patients were analyzed and entered into this study using two different tabulation methods: these spectra were not superimposable, the variation was negligible. DNF spectrum for each new fluorescence spectrum was collective data analysis and individual patient data analysis. Collective data analysis. In this technique, the fluodetermined by subtracting the baseline spectrum from the new normalized spectrum. DNF indices DNF 480 and DNF 660 were rescence spectra from all patients were analyzed collectively. DNF 480 and DNF 660 were used independent of each other to defined as the magnitude of the DNF spectrum at wavelengths of 480 nm and 660 nm. Four hundred eighty nanometers classify each spectrum as either benign or premalignant tissue. A total of 216 spectra were obtained from nondysplastic and 660 nm were selected because the normalized fluorescence spectra from normal and malignant esophageal tissue had sigBarrett's mucosa. Thirty-six spectra were obtained from mucosa with low-grade dysplasia, 10 spectra were obtained from nificant spectral differences around these wavelengths. 17 Development of the models using DNF 480 and DNF 660 indihigh-grade dysplasia, and 46 spectra were obtained from mucosa with low-grade dysplasia with focal high-grade dysplasia. ces to differentiate normal from malignant tissue were similar but only DNF 480 will be described as an example. A set of Individual patient data analysis. In the second technique, DNF 480 and one output. If any or both inputs are turned on, then the Barrett's mucosa. Figure 3B shows the corresponding DNF output will turn on. The output will be off only if both inputs spectrum for the high-grade dysplasia sample in Figure 2B .
are turned off. In this situation, if any (or both) of the DNF 480
The DNF spectrum for tissues with low-grade dysplasia was or DNF 660 indices classified even a single spectrum as premasimilar to that of nondysplastic Barrett's mucosa samples.
lignant (on), the diagnosis for that patient was premalignant
Using Figure 2A and B, small spectral difference can individual patient data analysis.
The criteria used for the diagnosis and grading of dysplasia have been published previously. 19 
Collective Data Analysis
In this study, it is assumed that nondysplastic Barrett's 
Results
grade dysplasia samples (9 of 10) were classified as premalignant tissue. In contrast, 28% of biopsy specimens with The DNF spectrum was calculated for each spectrum. Figure 2A shows a typical normalized fluorescence low-grade with focal high-grade dysplasia (13 of 46) were classified as premalignant tissue, a result anticipated because spectrum of nondysplastic Barrett's mucosa. Figure 2B shows the normalized fluorescence spectrum of a Barrett's of the focal nature of high-grade dysplasia in patients with mixed low-grade and focal high-grade dysplasia. mucosa with high-grade dysplasia. Figure 3A shows the corresponding DNF spectrum for the above nondysplastic
The specificity for detecting benign tissue in nondys-/ 5e0f$$0016 06-03-96 11:40:58 gasa WBS-Gastro plastic Barrett's mucosa was 96% (208 of 216), noting ing either benign or premalignant tissue. Sixteen of 23 patients with histologically nondysplastic Barrett's muthe definitions of benign and premalignant tissues previously described. The specificity for detecting benign cosa and all 6 patients with low-grade dysplasia were classified as having benign Barrett's mucosa. Seven patissue in low-grade dysplasia samples was 100% (36 of 36). The sensitivity for detecting premalignant tissue tients with nondysplastic Barrett's mucosa were classified as having premalignant sites. All patients with highwas 28% (13 of 46) and 90% (9 of 10) for samples with low-grade with focal high-grade dysplasia and for grade dysplasia, including those with low-grade with focal high-grade dysplasia, were classified as having presamples with high-grade dysplasia, respectively.
When the DNF 660 index was used to classify the specmalignant lesions. Using the individual patient data analysis, the specitra, the results were similar except that 95% of nondysplastic Barrett's mucosa samples (206 of 216) were classificity for detecting benign tissue in patients with nondysplastic Barrett's mucosa and those with low-grade dysplafied as benign tissue compared with 96% when using the DNF 480 index. sia was 70% (16 of 23) and 100% (6 of 6), respectively. The sensitivity for detecting premalignant tissue in paIndividual Patient Data Analysis tients with high-grade dysplasia was 100% (7 of 7). In the 7 patients with nondysplastic Barrett's mucosa Table 2 shows the individual patient data analysis.
that were classified as having premalignant lesions (false This technique classified each individual patient as hav- In an in vitro study, Richards-Kortum et al. 22 used
fluorescence excitation-emission matrices to identify the optimal excitation wavelength for obtaining fluorescence emission spectra that could be used to differentiate norpositive), only a small fraction of the spectra from each mal and pathological colonic tissue. They indicated that patient (except P311) was classified as premalignant. Taexcitation at 330, 370, and 430 { 10 nm was optimal ble 3 shows a list of these patients.
for this purpose. Cothren et al. 5 used a 370-nm excitation light to exDiscussion amine in vivo fluorescence of colonic tissue. Using a twodimensional scatter plot of fluorescence intensities at 460 LIF spectroscopy is a noninvasive technique that nm vs. 680 nm, they defined a straight line representing has been used to differentiate normal from malignant a decision surface that minimized the misclassified samtissue. Several reports have suggested endogenous fluoples. Using this technique, adenomas could be distinrescence differences between normal and malignant tisguished from nonadenomatous tissue in approximately sue. Alfano et al. 2 used different laser lines from an argon 97% of cases. laser to excite in vitro fluorescence of normal and maligPanjehpour et al. 6 used LIF with an excitation wavenant tissues from lung and breast tissue. Using two pairs length of 410 nm to diagnose esophageal cancer during of malignant and normal breast and lung tissue, they routine endoscopy using a new classification algorithm showed marked differences between spectra from normal called linear discriminate analysis. Using this technique, and cancerous samples. Additional data from this study normal esophagus could be distinguished from malignant have been published by Tang et al. 1 esophageal tissue with a sensitivity of 100% and a speciFluorescence imaging has been used to detect dysplasia ficity of 98%. Vo-Dinh et al. 17 described a new spectral and carcinoma in situ in lung. Lam et al. 20 described a analysis technique, DNF index, to distinguish normal fluorescence bronchoscope used to compliment whitefrom malignant tissues in the esophagus during routine light bronchoscopy. They stated that the sensitivity of endoscopy. Using DNF indices at 480 nm and 660 nm, fluorescence bronchoscopy was 50% greater than that esophageal cancer was distinguished from normal tissue of white-light bronchoscopy in detecting dysplasia and with a high degree of reliability. carcinoma in situ. They also indicated that moderate/ Many of these studies report detecting malignancies severe dysplasia could not be differentiated from carcithat are either visible or are palpable by the clinician. noma in situ because of significant overlap of data.
In contrast, spectroscopy offers the potential to diagnose LIF has been used for detection of premalignant lesions accurately premalignant changes, such as dysplasia, beof the gastrointestinal tract. In an in vitro study, Kapadia fore development of a visible lesion. In Barrett's esophaet al.
3 used a helium-cadmium laser for differentiation gus, the squamous lining of the esophagus is replaced of adenomatous polyps from normal mucosa and hyperby specialized columnar mucosa. 25 In patients with Barrett's esophagus with percent of tissues with high-grade dysplasia were classified as premalignant. Only 28% of the samples that were no apparent adenocarcinoma, the prevalence of positive dysplasia is 5%-10%. [26] [27] [28] [29] [30] Dysplasia may be found in histologically diagnosed as low grade with focal highgrade dysplasia were classified as premalignant. This is different levels of severity, including low-grade or highgrade dysplasia, with occasional mixed low-grade and to be expected when the data are collectively analyzed. Because multiple four-quadrant biopsy samples from the focal high-grade dysplasia. Altorki et al. 31 reported detecting carcinoma in 45% of the surgically resected specisame level are placed in the same histology vial for interpretation, a mixture of low-grade and high-grade samples mens from symptomatic patients with Barrett's esophagus who underwent surgery for high-grade dysplasia. might be included from the same level. However, when fluorescence measurements are conducted, each spectrum An established methodology that provides extensive is analyzed individually as either benign or premalignant, sampling for detecting dysplasia involves four-quadrant perhaps explaining why only 28% of the samples conbiopsy specimens taken at 2-cm intervals within the Bartaining low-grade with focal high-grade dysplasia were rett's mucosa. 16 However, this method is far from ideal. classified as premalignant. First, the focal nature of dysplasia creates the possibility of sampling error even when performing four-quadrant
The overall results of the collective data analysis using biopsies at 2-cm intervals. Second, performing endothe DNF 660 index were similar but not identical to those scopic biopsies in patients with long segments of Barobtained using the DNF 480 index. This suggests that rett's mucosa results in a prolonged procedure. Third, each DNF index may be used independently or the two bleeding during and after endoscopic biopsies interferes DNF indices may be used concurrently to improve the with the accuracy of determining the precise location of likelihood of detecting high-grade dysplasia. biopsies. In addition, bleeding may limit the number of An alternative tabulation technique was therefore biopsies that may be taken. Furthermore, there is always used; the logical OR 18 of the two DNF classifications a potential risk of greater bleeding after biopsy is perwas used to reduce the chance of misclassifying patients formed in patients with a coagulation disorder. Fourth, with high-grade dysplasia. If any of the two (or both) variability exists in the histological interpretation of DNF indices classified a spectrum as premalignant, the pinch biopsy samples by different laboratories, 19 creating final diagnosis was premalignant. A minimum of one concerns and problems for clinicians. premalignant spectrum in a patient was sufficient to Compared with pinch biopsies, optical biopsy offers cerplace that patient in the premalignant category. Using tain advantages. First, because of the rapidity of the fluothis technique, 100% of patients with any high-grade rescence measurement, the endoscopic LIF technique allows dysplasia were classified as having premalignant lesions. examination of a practically unlimited number of sites, However, 7 of 23 patients with nondysplastic Barrett's thereby reducing the sampling error, while reducing the mucosa (30%) were classified as having premalignant length of the procedure significantly at the same time.
lesions using this technique. The high rate of false posiTypically, 6-7 optical biopsies can be performed in the tives may be explained in several ways. First, this may time it takes to perform one pinch biopsy. In addition, the simply be caused by the limitation of the technique. noninvasive nature of the measurements allows for multiple Another possible explanation may arise from the high optical biopsies to be taken without any bleeding.
probability of sampling error when performing pinch Furthermore, this technique may potentially reduce the biopsies. It is quite possible that the optical biopsy samhuman variability in histological interpretation of biopsy pled tiny islands of high-grade dysplasia that the pinch samples by establishing a standard mathematical/statistibiopsy missed. Therefore, it is possible that the 30% cal technique for interpretation of the data. Last, the results false-positive result may not reflect a true false-positive of the optical biopsy can be available to the endoscopist result. Although a high rate of false-positive results was within minutes, perhaps seconds, rather than days. This obtained using this technique, only a small fraction of may allow the endoscopist to decide on further diagnostic spectra from each patient was classified as premalignant. studies or on a choice of treatment, possibly with impleHowever, in patients with high-grade dysplasia, a high mentation during the same procedure.
percentage of spectra in each patient was classified as premalignant, ranging from 50% to 100%. Using the The DNF index technique was applied in this study to determine if high-grade dysplasia associated with Bartwo DNF indices concurrently, all patients with highgrade dysplasia were classified as having premalignant rett's mucosa can be distinguished from nondysplastic Barrett's mucosa. Analyzing all data collectively using lesions, indicating that optical biopsy may be used as a reliable screening technique for detecting high-grade the DNF 480 , 96% of nondysplastic Barrett's and all lowgrade dysplasia samples were classified as benign. Ninety dysplasia in patients with Barrett's esophagus.
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